Los mejores oncólogos pediátricos del tratamiento de Retinoblastoma — TOP-16 médicos
acreditaciones:
- El Dr. Yesim Yildirim se especializa en el tratamiento del retinoblastoma.
- Los tratamientos incluyen quimioterapia, radioterapia y terapia con láser.
- Práctica internacional en Estados Unidos, Turquía, Israel y Reino Unido.
- Posee la certificación ESMO, lo que garantiza una experiencia en oncología de primer nivel.
- Miembro de ESMO y Escuela Europea de Oncología (ESO).
- Ofrece consultas en línea para pacientes con retinoblastoma en todo el mundo.
- Habla inglés, turco y ruso (nivel B1).
Experience
2021 - 2022
Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital
2021 - 2022
Department of Radiation Oncology, Biruni University Faculty of Medicine
2020 - 2021
Clinical Manager of Radiation Oncology, Medicana International Istanbul Hospital
2017 - 2020
Clinical Manager of Radiation Oncology, Neolife Medical Center
2016 - 2017
Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine
2011 - 2016
Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine
2010 - 2011
Department of Radiation Oncology, Eskişehir Osmangazi University Faculty of Medicine
2008 - 2010
Radiation Oncology Clinic, Samsun Training and Research Hospital (Education Coordinator)
2006
Medical Faculty, Dokuz Eylül University
2006 - 2008
Radiation Oncology Clinic, Samsun Mehmet Aydın State Hospital (Compulsory Service)
2000 - 2006
Medical Faculty, Dokuz Eylül University
Education
2022
Biruni University Faculty of Medicine, Department of Radiation Oncology, Faculty Member, Professor Doctor
2022
Anadolu University Open Education Faculty Undergraduate Program, Cultural Heritage and Tourism
2021
Feyziye Schools Foundation Işık University Health Services Vocational School, Faculty Member, Associate Professor Doctor
2017
Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Faculty Member
2017
Eskişehir Osmangazi University Faculty of Medicine, Department of Radiation Oncology, Associate Professor Doctor
2006
Samsun Training and Research Hospital, Specialist Doctor, Compulsory Service
2006
Dokuz Eylül University Faculty of Medicine, Department of Radiation Oncology, Medical Specialization
1998
Ege University, Faculty of Medicine
Mostrar más
| Cita con el médico | precio a consultar |
| Radioterapia para el cáncer colorrectal | $4000 - $6000 |
Ahmet Murat Sarıca
- Se especializa en opciones avanzadas de tratamiento del retinoblastoma.
- Los métodos de tratamiento incluyen quimioterapia, radioterapia y terapia con láser.
- Práctica internacional en Europa, Estados Unidos y Asia.
- Reconocido experto en oncología oftalmológica pediátrica.
- Certificado por la junta en Oftalmología, lo que garantiza atención y experiencia del más alto nivel.
- Miembro activo de destacadas sociedades de oftalmología y oncología.
- Ofrece consultas en línea para pacientes globales con retinoblastoma.
- Consultas en inglés y turco, ampliando la accesibilidad del paciente.
- El Dr. Alp Özkan se especializa en tratamientos avanzados para el retinoblastoma.
- Los métodos de tratamiento incluyen cirugía, quimioterapia, radioterapia y crioterapia.
- Práctica internacional en los Estados Unidos, mejorando la experiencia en la atención del retinoblastoma.
- Jefe de Oncología Pediátrica del Centro Médico Anadolu, especializado en cánceres infantiles.
- Oncólogo acreditado con profunda experiencia en neoplasias malignas pediátricas.
- Participa en consultas remotas para pacientes con retinoblastoma.
- Habla inglés y turco con fluidez, lo que facilita la comunicación integral con el paciente.
Undergraduate and Doctoral Education:
* 1992-1999 Ondokuz Mayıs University Faculty of Medicine
* 2002-2007 Inonu University, Faculty of Medicine, Child Health and Diseases,
Pediatrics Residency
* 2015-2018 Inonu University, Faculty of Medicine, Pediatrics, Pediatric
Hematology and Oncology Subspecialization
*2017-Ankara University, Pediatrics, Oncology minor residency (8 months)
Mostrar másacreditaciones:
Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:
Cell therapies in childhood cancers
Cancer immunology
Investigation of genetic pathways responsible for cancer and metastasis
Pulmonary microbiota
BAL transplantation
Mostrar más